This paper presents a comprehensive overview of Oncologic Cell Coagulastasis Therapy (OCCT), an innovative approach to cancer treatment that leverages cellular coagulation mechanisms. The methodology involves manipulating platelet production and cellular isolation techniques to target cancerous cells while supporting immune function. Through the strategic implementation of artificial agents and controlled mitosis induction, this treatment protocol demonstrates promising potential in oncological interventions. This paper examines the underlying mechanisms, methodology, clinical implications, and preliminary outcomes of OCCT, while addressing its limitations and future research directions.